Caisson Biotech is a wholly owned subsidiary of Heparinex, L.L.C., both portfolio companies of Emergent Technologies, Inc. Caisson uses novel, heparosan-based conjugates to enhance the therapeutic properties of pharmaceuticals by increasing product half-life, reducing immunogenicity, and increasing stability. Chief Scientist and Professor Dr. Paul L. DeAngelis at the University of Oklahoma Health Sciences Center developed the drug delivery platform. Emergent Technologies, Inc. is a leading innovation solutions company headquartered in Austin, Texas. To learn more about Caisson, visit: http://www.caissonbiotech.com
About Seton Healthcare
The Seton Healthcare Family, a faith-based non-profit organization founded in 1902 by the Daughters of Charity, is the leading provider of comprehensive, advanced health care and services in Central Texas.
Seton operates more than 90 clinical locations including five major medical centers, two community hospitals, three rural hospitals, an inpatient mental health hospital, three primary care clinics for the uninsured and several strategically located health facilities. The system offers the region’s only Level I Trauma Centers for adult and pediatric patients. Its insurance division works with commercial insurance companies, community physicians and Medicaid and Medical Access programs for low-income persons, to assist in the management of the region’s overall health.
Seton is home to The University of Texas Southwestern (UTSW) Medical Center’s Austin medical residency programs, as well as the Seton/UTSW Clinical Research Institute.
The organization’s role in education, research and spiritual programming furthers Seton’s mission to improve the health of the communities it serves, with special concern for the poor and the vulnerable, as it prepares the region’s next generation of clinicians. In Fiscal Year 2011, Seton
Page: 1 2 3 4 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry2
. Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies3
. Bioinformatics: Technologies and Global Markets4
. Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies Market (2012 - 2017)5
. Nanotechnologies in Bioscience, Live Webinar on May 106
. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System7
. Amphora Research Systems welcomes Advanced Polymer Monitoring Technologies8
. Cobalt Technologies Successfully Scales Commercial n-Butanol Production9
. Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing10
. Patheon to Feature its Complex Formulation Technologies Expertise at the Upcoming CPhI – P-MEC –ICSE – BioPh – Pharmatec – Medtec Japan – Conference11
. Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor